Australian Laureate Fellowships - Grant ID: FL200100124
Funder
Australian Research Council
Funding Amount
$3,372,617.00
Summary
Very small nanoparticles made to measure. The administration of therapeutic drugs is often unsuccessful as the drug is quickly cleared from the body. Nanoparticles have been shown to enhance the efficiency of the drug administration, as evidenced by the increasing number of nanoformulations on the market, although commercially available products have currently a range of shortcomings, some of them related to their size. This research program aims to develop a toolset that allows the design of ve ....Very small nanoparticles made to measure. The administration of therapeutic drugs is often unsuccessful as the drug is quickly cleared from the body. Nanoparticles have been shown to enhance the efficiency of the drug administration, as evidenced by the increasing number of nanoformulations on the market, although commercially available products have currently a range of shortcomings, some of them related to their size. This research program aims to develop a toolset that allows the design of very small nanoparticles that display enhanced biological activity. The outcome will be an in-depth understanding of the relationship between polymer structure and properties, which is not only important for nanomedicine, but other areas such as catalysis and sensors. Read moreRead less
A platform for the efficient optimisation of drug delivery using cross-linked micelles and thioclick-chemistry toward better anti-cancer treatment. The delivery of albendazole - an anti-cancer drug - will be improved by encapsulating the drug into nanoparticles. State of the art polymer chemistry will be employed to generate a versatile drug delivery system. The resulting nanoparticles will be able to better control drug delivery and to enhance cellular uptake of the drug.